Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,783.76
(
0.13%
)
News Focus
News Focus
Post# of 824202
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor082

Send PM Follow Ignore
Followers 5
Posts 5219
Boards Moderated 1
Alias Born 03/21/2024

Investor082

Re: improving post# 754487

Sunday, 03/16/2025 11:43:49 PM

Sunday, March 16, 2025 11:43:49 PM

Post# of 824202
Pre-revenue biotech doesn’t give LP and LG the right to consistently lie and dilute shareholders to oblivion. Quite a few successful pre-revenue biotechs raise money at increasing valuations. They execute relentlessly rather than coming up with excuses and lies for well over a decade.

Nothing will change after UK approval. Once a liar always a liar!

Only pumpers that are not invested wouldn't care about ROI and are OK with losing over 90% value in the last 10-12 years.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News